Definium Therapeutics (DFTX) Cash & Equivalents (2020 - 2026)
Definium Therapeutics' Cash & Equivalents came in at $655.27 million for Q2 2026, compared with $33.39 million a year earlier and up 149.6% from the prior quarter.
Powered by 
Analysis
Definium Therapeutics (DFTX) Cash & Equivalents (2020 - 2026) Analysis & Trends
At the end of FY2025, Definium Therapeutics' Cash & Equivalents was $257.84 million, down 5.8% from FY2024.
- Cash & Equivalents carries a five-year compound annual growth rate of 26.3% (FY2020 to FY2025).
- Going back by year, Cash & Equivalents was $273.74 million in FY2024 (+174.6%), $99.7 million in FY2023 (-29.9%), $142.14 million in FY2022 (+6.4%) and $133.54 million in FY2021 (+66.7%).
- The Q2 2026 figure represents the highest quarterly Cash & Equivalents in data going back to Q4 2020.
- Year-over-year, Cash & Equivalents increased in three of the last seven quarters, with growth averaging 41.4%.
- The fastest year-over-year change in Cash & Equivalents over five years came in Q1 2026 (growth of 216.8%), and the weakest in Q3 2025 (a decline of 93.2%).
- Business Quant data shows DFTX's Cash & Equivalents at $262.52 million (Q1 2026), $257.84 million (Q4 2025) and $19.96 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.54 Bn | 572.07 Bn | 17.26 Bn | 20.42 Bn |
| 2 | AbbVie | 467.01 Bn | 440.17 Bn | 12.70 Bn | 6.57 Bn |
| 3 | Merck | 367.16 Bn | 321.59 Bn | 12.21 Bn | 6.85 Bn |
| 4 | Novartis Ag | 277.56 Bn | 233.43 Bn | 11.24 Bn | 7.62 Bn |
| 5 | Astrazeneca | 258.23 Bn | 231.79 Bn | 12.86 Bn | 4.89 Bn |
| 6 | Amgen | 224.14 Bn | 179.54 Bn | 7.24 Bn | 13.99 Bn |
| 7 | Gilead Sciences | 187.30 Bn | 161.42 Bn | 6.22 Bn | 3.18 Bn |
| 8 | Pfizer | 163.47 Bn | 110.41 Bn | 10.94 Bn | 976.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.31 Bn | 105.31 Bn | 2.84 Bn | 6.14 Bn |
| 10 | Definium Therapeutics | 4.00 Bn | 4.00 Bn | - | 655.27 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 655.27 Mn |
| Mar 31, 2026 | 262.52 Mn |
| Dec 31, 2025 | 257.84 Mn |
| Sep 30, 2025 | 19.96 Mn |
| Jun 30, 2025 | 33.39 Mn |
| Mar 31, 2025 | 82.85 Mn |
| Dec 31, 2024 | 273.74 Mn |
| Sep 30, 2024 | 295.28 Mn |
| Jun 30, 2024 | 243.13 Mn |
| Mar 31, 2024 | 252.33 Mn |
| Dec 31, 2023 | 99.70 Mn |
| Sep 30, 2023 | 117.70 Mn |
| Jun 30, 2023 | 116.90 Mn |
| Mar 31, 2023 | 129.41 Mn |
| Dec 31, 2022 | 142.14 Mn |
| Sep 30, 2022 | 154.52 Mn |
| Jun 30, 2022 | 105.74 Mn |
| Mar 31, 2022 | 120.47 Mn |
| Dec 31, 2021 | 133.54 Mn |
| Dec 31, 2020 | 80.09 Mn |
API Access
Definium Therapeutics Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=DFTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "DFTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=DFTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();